USANA Health Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
October 24, 2023 at 04:05 pm EDT
Share
USANA Health Sciences, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 213.37 million compared to USD 233.3 million a year ago. Net income was USD 11.35 million compared to USD 14.93 million a year ago. Diluted earnings per share from continuing operations was USD 0.59 compared to USD 0.78 a year ago.
For the nine months, sales was USD 699.93 million compared to USD 770.64 million a year ago. Net income was USD 47.02 million compared to USD 56.56 million a year ago. Diluted earnings per share from continuing operations was USD 2.43 compared to USD 2.93 a year ago.
USANA Health Sciences, Inc. is a global direct-selling, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. The Company operates through one segment: Direct-selling. Its two geographic regions include Asia Pacific, and Americas and Europe. The Companyâs product lines include USANA Nutritionals Optimizers, Essentials/CellSentials, foods, personal care, skin care, and all others. The USANA Nutritionals Optimizers consist of supplements designed to meet individual health and nutritional needs. The Essentials/CellSentials product line includes vitamin and mineral supplements that provide total body nutrition. Its food product line includes meal replacement shakes, snack bars, and other related products. It also offers products designed for prenatal, infant, and young-child age groups in China. It distributes products internationally through direct selling, which entails person-to-person marketing and selling of products.
USANA HEALTH SCIENCES, INC. 
